Pharsight Signs Anapharm as PKS, WinNonlin® AutoPilot Customer
Pharsight announced that Anapharm, a PharmaNet company, has selected Pharsight Knowledgebase Server™ (PKS™) as its enterprise solution for secure storage and tracking of pharmacokinetic and pharmacodynamic (PK/PD) data.
Anapharm will use PKS as the repository for management, analysis and reporting of PK/PD data generated by the company’s network of Phase I and bioanalytical facilities, as well as for data coming from other sources. PKS will serve as the centerpiece of Anapharm’s PK/PD data management and analysis infrastructure, replacing systems offering limited capabilities to achieve their aggressive strategy in developing a leadership position in Phase I clinical trials.
Under the terms of the license agreement, Anapharm has also licensed Pharsight’s WinNonlin® AutoPilot and PKS Reporter™, both of which are integrated with PKS. WinNonlin AutoPilot is configurable software that research scientists can use to automate common or repetitive tasks during clinical PK analysis and to create report-ready tables and graphs. PKS Reporter is software for creation, management and electronic signature of clinical study reports for internal review and regulatory submission. PKS, WinNonlin AutoPilot and PKS Reporter will be used in conjunction with Anapharm’s existing licenses of WinNonlin®, Pharsight’s industry-standard software for PK/PD modeling and noncompartmental analysis.
“We look forward to putting PKS into production, and to utilizing Pharsight’s suite of products to better serve our global pharmaceutical and biotechnology industry customers who demand secure, compliant data tracking and analyses across development programs and indications,"said Mario Tanguay, Ph.D., Vice President of Scientific and Regulatory Affairs at Anapharm.
In a separate agreement, Anapharm has also expanded its use of Pharsight’s portfolio of PK/PD analysis and data management tools by licensing Phoenix® WinNonlin®, Phoenix® NLME™ and Phoenix® Connect™. Phoenix® is Pharsight's new desktop software platform that provides an integrated environment for analysis, modeling and simulation. Phoenix NLME provides new data processing and modeling tools for population PK/PD analysis.Phoenix Connect integrates applications built on the Phoenix platform with commonly used third-party analysis and modeling tools such as NONMEM®, R®, SAS® and S-PLUS®.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
